Antidiarrheal
A 2012 study concluded that cannabichromene reduced the inflammation-induced hypermotility AKA diarrhea. They found that the cannabinoid activated the transient receptor TRPA1 which may modulate gastrointestinal motility.
Further research needs to be done to see if it can help with other conditions that negatively affect the gastrointestinal system.
